Meng MV - Search Results

1

Outcomes of active surveillance for men with intermediate-risk prostate cancer.

Cooperberg MR, Cowan JE, Hilton JF, Reese AC, Zaid HB, Porten SP, Shinohara K, Meng MV, Greene KL, Carroll PR. Cooperberg MR, et al. Among authors: meng mv. J Clin Oncol. 2011 Jan 10;29(2):228-34. doi: 10.1200/JCO.2010.31.4252. Epub 2010 Nov 29. J Clin Oncol. 2011. PMID: 21115873 Free PMC article.

2

When is pelvic lymph node dissection necessary before radical prostatectomy? A decision analysis.

Meng MV, Carroll PR. Meng MV, et al. J Urol. 2000 Oct;164(4):1235-40. J Urol. 2000. PMID: 10992372

3

Minichromosome maintenance protein 2 expression in prostate: characterization and association with outcome after therapy for cancer.

Meng MV, Grossfeld GD, Williams GH, Dilworth S, Stoeber K, Mulley TW, Weinberg V, Carroll PR, Tlsty TD. Meng MV, et al. Clin Cancer Res. 2001 Sep;7(9):2712-8. Clin Cancer Res. 2001. PMID: 11555583

4

Thrombospondin-1 expression in patients with pathologic stage T3 prostate cancer undergoing radical prostatectomy: association with p53 alterations, tumor angiogenesis, and tumor progression.

Grossfeld GD, Carroll PR, Lindeman N, Meng M, Groshen S, Feng AC, Hawes D, Cote RJ. Grossfeld GD, et al. Urology. 2002 Jan;59(1):97-102. doi: 10.1016/s0090-4295(01)01476-5. Urology. 2002. PMID: 11796289

5

Origin of urothelial carcinoma after renal transplant determined by fluorescence in situ hybridization.

Master VA, Meng MV, Koppie TM, Carroll PR, Grossfeld GD. Master VA, et al. Among authors: meng mv. J Urol. 2002 Jun;167(6):2521-2. J Urol. 2002. PMID: 11992074 No abstract available.

6

Is it necessary to do staging pelvic lymph node dissection for T1c prostate cancer?

Meng MV, Carroll PR. Meng MV, et al. Curr Urol Rep. 2001 Jun;2(3):237-41. doi: 10.1007/s11934-001-0085-x. Curr Urol Rep. 2001. PMID: 12084271 Review.

7

Neoadjuvant strategies for prostate cancer prior to radical prostatectomy.

Meng MV, Grossfeld GD, Carroll PR, Small EJ. Meng MV, et al. Semin Urol Oncol. 2002 Aug;20(3 Suppl 1):10-8. doi: 10.1053/suro.2002.35055. Semin Urol Oncol. 2002. PMID: 12198633 Review.

8

Contemporary patterns of androgen deprivation therapy use for newly diagnosed prostate cancer.

Meng MV, Grossfeld GD, Sadetsky N, Mehta SS, Lubeck DP, Carroll PR. Meng MV, et al. Urology. 2002 Sep;60(3 Suppl 1):7-11; discussion 11-2. doi: 10.1016/s0090-4295(02)01560-1. Urology. 2002. PMID: 12231037

9

Sociodemographic characteristics and health related quality of life in men attending prostate cancer support groups.

Katz D, Koppie TM, Wu D, Meng MV, Grossfeld GD, Sadesky N, Lubeck DP, Carroll PR. Katz D, et al. Among authors: meng mv. J Urol. 2002 Nov;168(5):2092-6. doi: 10.1016/S0022-5347(05)64303-0. J Urol. 2002. PMID: 12394716

10

Surgery for prostate cancer: rationale, technique and outcomes.

Downs TM, Kane CJ, Grossfeld GD, Meng MV, Carroll PR. Downs TM, et al. Among authors: meng mv. Cancer Metastasis Rev. 2002;21(1):29-44. doi: 10.1023/a:1020164206406. Cancer Metastasis Rev. 2002. PMID: 12400995 Review.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

207 results

Search Page